Ensysce Biosciences Inc. (ENSC)
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Curaleaf Celebrates Launch of Adult-Use Sales in Maine at Bangor Dispensary
Agenus Inc. - Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
Bausch Health Notification
Exicure, Inc. - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer